Slotnik Capital’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Slotnik Capital’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-85,000	Closed	-$5.28M	–	27
2023 Q4	$5.28M	Buy	+85,000	New	+$2.11M	3.15%	11

Slotnik Capital's RYZB Position: Q1 2024 in Review

Slotnik Capital sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 85,000 shares — an estimated $5.28M sold.

Slotnik Capital first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $5.28M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Slotnik Capital reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Slotnik Capital sold 85,000 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $5.28M.
Slotnik Capital first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Slotnik Capital's RayzeBio, Inc. Common Stock position peaked at $5.28M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Slotnik Capital's 13F filing for Q1 2024, filed 15 May 2024.